- Home
- ENTX vs STSS Comparison
ENTX vs STSS Comparison
Compare ENTX & STSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ENTX | STSS |
|---|---|---|
| Founded | 2010 | 2017 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.7M | 68.7M |
| IPO Year | 2018 | 2022 |
Fundamental Metrics
Financial Performance| Metric | ENTX | STSS |
|---|---|---|
| Price | $1.48 | $2.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | 269.3K | ★ 1.0M |
| Earning Date | 11-14-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $124,000.00 | ★ $306,344.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 25.25 | N/A |
| 52 Week Low | $1.45 | $1.65 |
| 52 Week High | $3.22 | $519.01 |
Technical Indicators
Market Signals| Indicator | ENTX | STSS |
|---|---|---|
| Relative Strength Index (RSI) | 36.56 | 48.60 |
| Support Level | $1.52 | $2.08 |
| Resistance Level | $1.64 | $2.27 |
| Average True Range (ATR) | 0.14 | 0.21 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 4.29 | 66.87 |
Price Performance
Historical ComparisonAbout ENTX Entera Bio Ltd.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
About STSS Sharps Technology Inc.
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes designed to eliminate potentially infectious and accidental needlestick injuries.